Although the possibility that the Pdia4/Stat3/Vegf axis also functions in cancer cells could not be excluded, both lines of evidence suggest that targeting Pdia4 in the cancer stroma and cancer cells is a promising two‐pronged approach to treating lung cancer. The gene discussed is STAT3; the disease is lung cancer.